TN2010000377A1 - Forms of rifaximin and uses thereof - Google Patents

Forms of rifaximin and uses thereof

Info

Publication number
TN2010000377A1
TN2010000377A1 TNP2010000377A TN2010000377A TN2010000377A1 TN 2010000377 A1 TN2010000377 A1 TN 2010000377A1 TN P2010000377 A TNP2010000377 A TN P2010000377A TN 2010000377 A TN2010000377 A TN 2010000377A TN 2010000377 A1 TN2010000377 A1 TN 2010000377A1
Authority
TN
Tunisia
Prior art keywords
rifaximin
forms
hydrate
salt
relates
Prior art date
Application number
TNP2010000377A
Other languages
French (fr)
Inventor
Karen S Gushurst
Donglai Yang
Melanie Roe
Nathan Schultheiss
Petinka Vlahova
Jeffrey S Stults
Travis L Houston
Original Assignee
Salix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/035192 external-priority patent/WO2009108730A2/en
Application filed by Salix Pharmaceuticals Ltd filed Critical Salix Pharmaceuticals Ltd
Publication of TN2010000377A1 publication Critical patent/TN2010000377A1/en

Links

Abstract

The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
TNP2010000377A 2009-02-25 2010-08-12 Forms of rifaximin and uses thereof TN2010000377A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/035192 WO2009108730A2 (en) 2008-02-25 2009-02-25 Forms of rifaximin and uses thereof

Publications (1)

Publication Number Publication Date
TN2010000377A1 true TN2010000377A1 (en) 2011-12-29

Family

ID=55024504

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000377A TN2010000377A1 (en) 2009-02-25 2010-08-12 Forms of rifaximin and uses thereof

Country Status (1)

Country Link
TN (1) TN2010000377A1 (en)

Similar Documents

Publication Publication Date Title
MY158257A (en) Forms of rifaximin and uses thereof
TN2012000414A1 (en) Forms of rifaximin and uses thereof
PH12018501404A1 (en) Forms of rifaximin and uses thereof
PL2590976T3 (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
AP2011005943A0 (en) Atropisomers of 2-purinyl-3-tolylquinazolinone derivatives and methods of use.
IL231386A (en) Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
HK1153926A1 (en) Purin derivatives for use in the treatment of fab-related diseases fab-
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
IL232906A0 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
PL2726470T3 (en) 1,2,4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases
IL215103A0 (en) N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME
PL392436A1 (en) Arylsulphonamide derivatives for treating the diseases of the central nervous system
IL225755A0 (en) 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
EP2488507A4 (en) Novel mek inhibitors, useful in the treatment of diseases
AP2011005798A0 (en) Use of ammonium chloride in therapy.
HK1164861A1 (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
PL2477990T3 (en) 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof
TN2010000377A1 (en) Forms of rifaximin and uses thereof
SI2421864T1 (en) 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof
HK1188565A1 (en) Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans
HUP0900305A2 (en) Peptide derivatives, process for their preparation and their therapeutical use